Could microglia hold the key to treating neurodegenerative diseases? This week on Careers in Discovery, Emma Hobbs is with David Gray, Chief Scientific Officer at Vigil Neuroscience, who is pioneering new approaches to harness the brain’s immune system.

David shares his unique career journey, from aspiring author to leading drug discovery programs at Pfizer and now in Biotech. He reflects on the power of curiosity, mentorship, and cross-disciplinary learning that shaped his path to leadership.

In this episode, David and Emma discuss Vigil's ground-breaking work in targeting ALSP and Alzheimer’s disease, the lessons he’s learned transitioning from big pharma to Biotech, and why having fun is essential to building a fulfilling scientific career.

Join us for an inspiring conversation about leadership, innovation, and advancing treatments for patients in need.